VSTM2A and colorectal carcinoma: Pathological examination of the tumors developed in Vstm2a+/− mice further confirmed high-grade dysplasia and adenocarcinoma, whereas normal colon epithelium or limited low-grade dysplasia were observed in the control group, echoing our previous report of VSTM2A as a tumor suppressor in CRC (Figure 2A).